Avantor, Inc. AVTR
NYSE · United States · Health Technology
$15.05-0.19 (-1.25%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, will release its third quarter 2026 financial results before the market opens on Wednesday, October 28, and will hold a related conference call on the same day at 8:00 a.m. Eastern Time.
Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.
Avantor has appointed Todd Garner as Executive Vice President and Chief Financial Officer, effective 21 September 2026, placing him in charge of its global finance organization, including planning, accounting, treasury, tax, investor relations and internal audit. Garner’s three decades of finance and public company leadership, including prior CFO roles and extensive investor relations experience, could meaningfully influence Avantor’s capital allocation and communication with the...
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.